Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 3/20 | 0.40 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | BCL9 | O00512 | 1/20 | 0.34 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14583933 | 0.88 | F13A1 (0.41) | — | |
| SCHEMBL14569797 | 0.88 | F13A1 (0.41) | — | |
| SCHEMBL12142687 | 0.88 | F13A1 (0.41) | — | |
| SCHEMBL7850110 | 0.88 | F13A1 (0.41) | — | |
| SCHEMBL12600876 | 0.86 | F13A1 (0.41) | MGLLMMP2ANPEPGAAMAPT | |
| SCHEMBL12141232 | 0.86 | THRB (0.36) | MGLLMMP2ANPEPGAAMAPT | |
| SCHEMBL14073406 | 0.85 | AGTR2 (0.40) | MGLLMMP2ANPEPGAAMAPT | |
| SCHEMBL8280794 | 0.83 | ALDH1A1 (0.35) | MGLLMMP2ANPEPGAAMAPT | |
| SCHEMBL16313133 | 0.78 | MGLL (0.35) | MGLLGAAALDH1A1 | |
| SCHEMBL30556816 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006130666-A2 | MEDICAMENTS AND METHODS COMBINING A HCV PROTEASE INHIBITOR AND AN AKR COMPETITOR | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006130554-A2 | METHODS OF TREATING HEPATITIS C VIRUS | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |